全文获取类型
收费全文 | 6897篇 |
免费 | 617篇 |
国内免费 | 36篇 |
专业分类
耳鼻咽喉 | 53篇 |
儿科学 | 314篇 |
妇产科学 | 204篇 |
基础医学 | 954篇 |
口腔科学 | 159篇 |
临床医学 | 728篇 |
内科学 | 1492篇 |
皮肤病学 | 125篇 |
神经病学 | 667篇 |
特种医学 | 345篇 |
外国民族医学 | 1篇 |
外科学 | 1113篇 |
综合类 | 47篇 |
一般理论 | 4篇 |
预防医学 | 416篇 |
眼科学 | 144篇 |
药学 | 323篇 |
1篇 | |
中国医学 | 6篇 |
肿瘤学 | 454篇 |
出版年
2022年 | 49篇 |
2021年 | 86篇 |
2020年 | 69篇 |
2019年 | 85篇 |
2018年 | 109篇 |
2017年 | 80篇 |
2016年 | 125篇 |
2015年 | 102篇 |
2014年 | 159篇 |
2013年 | 191篇 |
2012年 | 297篇 |
2011年 | 311篇 |
2010年 | 187篇 |
2009年 | 184篇 |
2008年 | 287篇 |
2007年 | 324篇 |
2006年 | 296篇 |
2005年 | 337篇 |
2004年 | 316篇 |
2003年 | 318篇 |
2002年 | 295篇 |
2001年 | 255篇 |
2000年 | 263篇 |
1999年 | 225篇 |
1998年 | 121篇 |
1997年 | 116篇 |
1996年 | 114篇 |
1995年 | 113篇 |
1994年 | 77篇 |
1993年 | 73篇 |
1992年 | 129篇 |
1991年 | 125篇 |
1990年 | 122篇 |
1989年 | 145篇 |
1988年 | 110篇 |
1987年 | 111篇 |
1986年 | 107篇 |
1985年 | 91篇 |
1984年 | 91篇 |
1983年 | 70篇 |
1982年 | 59篇 |
1981年 | 41篇 |
1980年 | 41篇 |
1979年 | 70篇 |
1978年 | 51篇 |
1977年 | 41篇 |
1976年 | 54篇 |
1975年 | 44篇 |
1974年 | 42篇 |
1972年 | 40篇 |
排序方式: 共有7550条查询结果,搜索用时 15 毫秒
101.
102.
103.
104.
Blumhardt LD Vermeij BJ Amato M Andersen O Edan G Fernandez O Filippi M Haas J Hommes OR Rieckmann P 《Multiple sclerosis (Houndmills, Basingstoke, England)》2000,6(4):231-236
The urgent need to optimise treatment strategies for patients with Multiple Sclerosis (MS) was recognised by the participants at the 1998 European Charcot Foundation (ECF) symposium in Nice. The 'Nice Declaration' led to the formation of a Task Force Essentials Group charged with developing measures of the quality of MS care in Europe. Algorithms for nine critical domains (disability, spasticity, ataxia, pain, cognition, mood, fatigue, bladder function and sexual activity) and 'educated guesses' have been developed to measure interventions and outcomes which reflect the quality of clinical decision-making processes. A generic model called a 'quality network', consisting of a group of clinics connected to a central server, has been successfully applied to the care of diabetes across Europe. This model will now be developed and applied to MS management, to provide clinicians with longitudinal epidemiological data and, to evolve treatment algorithms and further quality measures. The ECF will next validate the system in a 1-year pilot study using a net of 10 clinics. Finally, an extended European network working in a learning environment will continuously assess, update and improve the quality of care of MS patients. Multiple Sclerosis (2000) 6 231 - 236 相似文献
105.
Marina Kartachova Rick L M Haas Renato A Valdés Olmos Frank J P Hoebers Nico van Zandwijk Marcel Verheij 《Radiotherapy and oncology》2004,72(3):333-339
BACKGROUND AND PURPOSE: Anticancer therapy induces apoptosis in a dose- and time-dependent fashion. (99m)Tc-Hynic-rh-Annexin V scintigraphy (TAVS) enables non-invasive in vivo imaging of treatment-induced apoptosis. We identified the visual patterns of (99m)Tc-Hynic-rh-Annexin V tumour uptake and related these to treatment response. PATIENTS AND METHODS: Thirty-three patients with malignant lymphoma (n=26), leukaemia (n=1) NSCLC (n=5), H&NSCC (n=1), scheduled for radiotherapy (n=27), platinum-based chemotherapy (n=5) or concurrent chemoradiation (n=1), underwent TAVS before and early after the start of treatment. Planar and SPECT images were visually examined to assess changes in tumour (99m)Tc-Hynic-rh-Annexin V uptake. Twenty-nine patients were eligible for further analysis. Annexin V uptake before (U(baseline)) and early after (U(post)) the start of treatment was graded using a four-step scale: 0, absent; 1, weak; 2, moderate and 3, intense. The difference between these values (Delta U) was calculated and correlated to tumour response after therapy (Spearman rank correlation test). RESULTS: Weak to moderate U(baseline) was detected in 13/15 patients with a complete response and U(post) was markedly increased in all these cases (Delta U range 1-3). Partial response (n=7) was associated with weak to moderate U(baseline) and a moderately increased U(post) (Delta U range 1-2). In patients with stable disease (n=5), U(baseline) was predominantly weak, without considerable changes in uptake after the start of treatment (Delta U range 0-1). Finally, in case of progressive disease (n=2), either no tumour uptake or a decrease in U(post) was detected (Delta U=-1). A statistically significant correlation was found between changes in (99m)Tc-Hynic-rh-Annexin V tumour uptake and clinical response (correlation coefficient=0.62; P<0.001). CONCLUSIONS: Complete or partial tumour response was associated with a marked increase of (99m)Tc Hynic-rh-Annexin V accumulation early during treatment compared to baseline values. In case of stable or progressive disease, pretreatment scans demonstrated predominantly low (99m)Tc Hynic-rh-Annexin V tumour uptake and no significant increase early after treatment. These results indicate that TAVS might be useful as a predictive test for treatment response. 相似文献
106.
A Weltermann C Fonatsch O A Haas H T Greinix P Kahls G Mitterbauer U J?ger B Kainz K Geissler P Valent W R Sperr P Kn?bl I Schwarzinger A Gleiss K Lechner 《Leukemia》2004,18(2):293-302
Karyotype is an important prognostic factor in patients with newly diagnosed acute myeloblastic leukaemia (AML). The prognostic value of cytogenetics on the outcome of patients with AML in relapse has not yet been well defined. We analysed the clinical outcome of 152 patients with de novo, chemotherapy-treated AML in first relapse according to the cytogenetic classification of the United Kingdom Medical Research Council. The rate of second complete remission (CR) (88, 64 and 36%) and the probability of survival at 3 years (43, 18 and 0%) were significantly different between the favourable, intermediate and adverse cytogenetic risk groups, respectively. Compared to the favourable group, the relative risk (RR) of death (multivariate analyses) was 2.6 (confidence interval (CI): 1.5-4.4, P<0.001) for the intermediate and 3.7 (CI: 1.7-7.9, P=0.001) for the adverse group. The prognostic value of the duration of first CR was confirmed (RR of death: 2.0 (CI: 1.0-4.0) for each additional year in first CR), whereas the FLT3 mutation obtained at diagnosis did not markedly influence the outcome of patients with AML in relapse. In conclusion, our results indicate that both karyotype and the duration of first CR are independent prognostic factors for patients with de novo AML in first relapse. 相似文献
107.
108.
PAX5/ETV6 fusion defines cytogenetic entity dic(9;12)(p13;p13). 总被引:4,自引:0,他引:4
109.
SK Roy AM Tomkins SM Akramuzzaman RH Behrens R Haider D Mahalanabis G Fuchs 《Archives of disease in childhood》1997,77(3):196-200
OBJECTIVE: To evaluate the impact of zinc supplementation on the clinical course, stool weight, duration of diarrhoea, changes in serum zinc, and body weight gain of children with acute diarrhoea. DESIGN: Randomised double blind controlled trial. Children were assigned to receive zinc (20 mg elemental zinc per day) containing multivitamins or control group (zinc-free multivitamins) daily in three divided doses for two weeks. SETTING: A diarrhoeal disease hospital in Dhaka, Bangladesh. PATIENTS: 111 children, 3 to 24 months old, below 76% median weight for age of the National Center for Health Statistics standard with acute diarrhoea. Children with severe infection and/or oedema were excluded. MAIN OUTCOME MEASURES: Total diarrhoeal stool output, duration of diarrhoea, rate of weight gain, and changes in serum zinc levels after supplementation. RESULTS: Stool output was 28% less and duration 14% shorter in the zinc supplemented group than placebo (p = 0.06). There were reductions in median total diarrhoeal stool output among zinc supplemented subjects who were shorter (less than 95% height for age), 239 v 326 g/kg (p < 0.04), and who had a lower initial serum zinc (< 14 mmol/l), 279 v 329 g/kg (p < 0.05); a shortening of mean time to recovery occurred (4.7 v 6.2 days, p < 0.04) in those with lower serum zinc. There was an increase in mean serum zinc in the zinc supplemented group (+2.4 v -0.3 mumol/l, p < 0.001) during two weeks of supplementation, and better mean weight gain (120 v 30 g, p < 0.03) at the time of discharge from hospital. CONCLUSIONS: Zinc supplementation is a simple, acceptable, and affordable strategy which should be considered in the management of acute diarrhoea and in prevention of growth faltering in children specially those who are malnourished. 相似文献
110.